Contraline

Drug Discovery · Charlottesville, VA · Founded 2015 · Privately Held (backing)

Developer of a male contraceptive product intended to provide non-surgical and reversible birth control procedures. Contraline is based in Charlottesville, VA and was founded in 2015. Its last reported valuation was $60 million in Feb 2025. It has raised $41.7 million across 3 recorded rounds; the latest was a $55.8 million later-stage round in May 2026.

Last reported valuation
$60.0M
Oct 2026
Priced at
—
Total raised
$41.7M
Last round
Later Stage VC
May 2026
Cap table — not yet on record

Contraline's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Contraline with a free account
  • ·The complete investor list: 52 names
  • ·Watch Contraline: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Contraline

Where does Contraline's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Contraline's 3 recorded funding rounds.